Apimeds Pharmaceuticals US (APUS) Payables (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Payables came in at $7.1 million in Q4 2025, up 743.0% YoY from $841191.0 in Q4 2024, and up 1149.27% on a QoQ basis from $567633.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Payables (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Payables data on file, last reported at $7.1 million in Q4 2025.
- Quarterly Payables rose 743.0% year-over-year to $7.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.1 million (up 743.0% YoY) and the FY2025 annual result came in at $7.1 million, up 743.0% from the prior year.
- Payables advanced to $7.1 million in Q4 2025, from $567633.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $7.1 million in Q4 2025 to a low of $119138.0 in Q2 2025.
- A 3-year average of $1.7 million and a median of $704412.0 in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables soared 161.78% — and 2025, when it surged 743.0%.
- Tracing APUS's Payables over 3 years: stood at $321329.0 in 2023, then surged by 161.78% to $841191.0 in 2024, then surged by 743.0% to $7.1 million in 2025.
- The last three Payables figures came in at $7.1 million (Q4 2025), $567633.0 (Q3 2025), and $119138.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 986.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 7.20 Mn | 7.20 Mn | - | 8.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.09 Mn |
| Sep 30, 2025 | 567,633.00 |
| Jun 30, 2025 | 119,138.00 |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 841,191.00 |
| Dec 31, 2023 | 321,329.00 |